Rakuten Securities’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.61K Buy
+70
New +$5.34K ﹤0.01% 615
2026
Q2
– Sell
-170
Closed -$11.2K – 942
2026
Q1
$11.2K Buy
170
+120
+240% +$7.63K ﹤0.01% 410
2025
Q4
$3.18K Buy
+50
New +$3.11K ﹤0.01% 574

Other funds holding CYTK

Rakuten Securities's CYTK Position: Q3 2026 in Review

Rakuten Securities opened a new position in Cytokinetics (CYTK) in Q3 2026: 70 shares worth $4.61K. The stake represents ﹤0.01% of the portfolio and ranks #615 among its holdings. This is a return to the name: Rakuten Securities previously reported a position in CYTK as recently as Q1 2026.

Rakuten Securities first reported a position in CYTK in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.2K in Q1 2026. 473 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • Rakuten Securities held 70 shares of Cytokinetics worth $4.61K as of Q3 2026.
  • Cytokinetics was a new Rakuten Securities position in Q3 2026.
  • Cytokinetics made up ﹤0.01% of Rakuten Securities's portfolio in Q3 2026, its #615 holding.
  • Rakuten Securities first reported a position in Cytokinetics in Q4 2025 and has held it in 3 quarters since.
  • Rakuten Securities's Cytokinetics position peaked at $11.2K in Q1 2026.
  • 473 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on Rakuten Securities's 13F filing for Q3 2026, filed 2 Nov 2026.